HFE Gene Mutations in Chile
- Nelson Wohllk, MD;
- Rodrigo Zapata, MD;
- Mónica Acuña, MSc;
- Humberto Reyes, MD;
- Alex Navarro, MD;
- Iván Roa, MD; and
- Juan Carlos Roa, MD
- From University of Chile School of Medicine Casilla 16038, Santiago, Chile; University of Valparaíso and Chilean Air Force Hospital Casilla 27013, Santiago, Chile; and Universidad de La Frontera Casilla 54-D, Temuco, Chile. Grant Support: By grants 1980135 and 1010648 from Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT).
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
Background: The prevalence of hereditary hemochromatosis varies among countries and geographic regions, apparently influenced by the ethnic origin of the local population and by the prevalence of allele variants C282Y and H63D in the HFE gene on chromosome 6 (1, 2). The current population of Chile is predominantly white but includes vestiges of an …
RSS Feeds









